Rx (Prescription Medicine)
USD $ 162.00
Carzomib 60毫克注射液是一种靶向治疗药物，用于治疗多发性骨髓瘤（一种血癌）。本品由医疗专业人员静脉给药。
Carzomib 60毫克注射液是一种靶向治疗药物，用于治疗多发性骨髓瘤（一种血癌）。其活性成分卡非佐米（carfilzomib）是一种蛋白酶体抑制剂，通过阻断蛋白酶体的作用发挥疗效。蛋白酶体负责分解细胞内不需要或受损的蛋白质。通过抑制蛋白酶体，Carzomib 导致癌细胞中异常蛋白质的积累，最终导致癌细胞死亡。本品由医疗专业人员静脉给药。患者应告知医生任何既往病史，特别是心脏问题、肺部疾病或肾脏问题，以及正在服用的任何其他药物。Carzomib 60毫克注射液应在室温下储存，避光防潮，并置于儿童接触不到的地方。
| Brand Name | |
|---|---|
| Molecule | |
| Strength | |
| Pack Quantity | |
| Medicine Form | |
| Medicine Type | |
| Rx Status | |
| Country Of Origin | |
| Packaging Type |
其他品牌的 Carfilzomib 60 Mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
